Jules Abraham | Investor Relations |
David Dodd | Chairman and Chief Executive Officer |
Mark Newman | Chief Scientific Officer |
Mark Reynolds | Chief Financial Officer |
John Sharkey | Head, Business Development |
Don Diamond | Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope |
Jason McCarthy | Maxim Group |
Good afternoon and welcome everyone to the GeoVax Third Quarter 2021 Corporate Update Call. I am Rocco with Chorus Call and will facilitate today’s call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, Ph.D., Chief Scientific Officer; John Sharkey, Ph.D., Head, Business Development; and Don Diamond, Ph.D., Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded.